Avantax Planning Partners, Inc. Emergent Bio Solutions Inc. Transaction History

Avantax Planning Partners, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 27, 2020	SELL	$49.34 - $68.76 $286,221 - $398,876	-5,801 Closed	0 $0
Q4 2019 Jan 15, 2020	BUY	$51.21 - $59.06 $60,222 - $69,454	1,176 Added 25.43%	5,801 $313,000
Q3 2019 Nov 08, 2019	BUY	$40.6 - $57.2 $187,775 - $264,550	4,625 New	4,625 $242,000
Q4 2018 Feb 14, 2019	SELL	$55.63 - $73.24 $44,504 - $58,591	-800 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$52.05 - $66.51 $41,640 - $53,208	800 New	800 $53,000
Q2 2018 Aug 13, 2018	SELL	$48.33 - $55.64 $7,249 - $8,346	-150 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$44.44 - $54.39 $6,666 - $8,158	150 New	150 $8,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Avantax Planning Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Avantax Planning Partners, Inc. with notifications on news.